Sam Brusco, Associate Editor09.25.23
Dexcom and RxFood Corporation, a developer of artificial intelligence (AI)-driven personalized nutrition assessments, began a partnership in Canada to introduce a better digital health solution for diabetes patients.
The next-gen RxFood app with Dexcom continuous glucose monitoring (CGM) data integration is now available to clinical, hospitals, health authorities, pharmacies, insurers, and employers across Canada to incorporate into diabetes and nutrition management programming.
The pair said that Canadians using Dexcom G6 or G7—once commercially available—will have access to a combination of food and glucose data to receive a more in-depth, personalized understanding of their health and glycemic control.
"At Dexcom, introducing industry-leading technology that transforms day-to-day diabetes management for users around the world has been our primary goal for over two decades," Dexcom Canada’s VP and GM André Côté told the press. “Working closely with RxFood on this innovative solution has allowed us to advance this even further. We look forward to demonstrating how our partnership will help continue to simplify diabetes management for individuals and families, providing deep, actionable nutritional insights to enhance overall health."
In the RxFood app, Dexcom CGM users can take photos of meals to remove the need for manual food and nutrition tracking. As their food is photo-logged, the app will continuously create detailed diet quality metrics combined with glycemic data that is easily accessible to patients and their clinicians.
RxFood’s effectiveness was shown through a three-year clinical trial at the Hospital for Sick Children in Toronto. The study yielded improved accuracy in carbohydrate counting, decrease in counting errors exceeding 10g, and lower A1c levels. The company said that in clinical settings throughout Canada, RxFood helped lower time associated with day-to-day diabetes management for parents and allow more complete food records for clinicians.
With all of this, the duo hopes to support development of more personalized care recommendations for families.
“Continuous glucose monitoring is a key component of diabetes management, but food type, amount, and timing are also important variables. By seamlessly integrating food data with insulin dosing, exercise, and glucose information, a comprehensive understanding of how specific food items impact glucose levels is made possible,” said Dr. Jeffrey Alfonsi, MD, Internist & Obesity Medicine Physician and chief medical officer at RxFood. “These invaluable insights empower both patients and clinicians to enhance diabetes management by identifying and addressing factors that contribute to glucose excursions, leading to improved overall control and care.”
The next-gen RxFood app with Dexcom continuous glucose monitoring (CGM) data integration is now available to clinical, hospitals, health authorities, pharmacies, insurers, and employers across Canada to incorporate into diabetes and nutrition management programming.
The pair said that Canadians using Dexcom G6 or G7—once commercially available—will have access to a combination of food and glucose data to receive a more in-depth, personalized understanding of their health and glycemic control.
"At Dexcom, introducing industry-leading technology that transforms day-to-day diabetes management for users around the world has been our primary goal for over two decades," Dexcom Canada’s VP and GM André Côté told the press. “Working closely with RxFood on this innovative solution has allowed us to advance this even further. We look forward to demonstrating how our partnership will help continue to simplify diabetes management for individuals and families, providing deep, actionable nutritional insights to enhance overall health."
In the RxFood app, Dexcom CGM users can take photos of meals to remove the need for manual food and nutrition tracking. As their food is photo-logged, the app will continuously create detailed diet quality metrics combined with glycemic data that is easily accessible to patients and their clinicians.
RxFood’s effectiveness was shown through a three-year clinical trial at the Hospital for Sick Children in Toronto. The study yielded improved accuracy in carbohydrate counting, decrease in counting errors exceeding 10g, and lower A1c levels. The company said that in clinical settings throughout Canada, RxFood helped lower time associated with day-to-day diabetes management for parents and allow more complete food records for clinicians.
With all of this, the duo hopes to support development of more personalized care recommendations for families.
“Continuous glucose monitoring is a key component of diabetes management, but food type, amount, and timing are also important variables. By seamlessly integrating food data with insulin dosing, exercise, and glucose information, a comprehensive understanding of how specific food items impact glucose levels is made possible,” said Dr. Jeffrey Alfonsi, MD, Internist & Obesity Medicine Physician and chief medical officer at RxFood. “These invaluable insights empower both patients and clinicians to enhance diabetes management by identifying and addressing factors that contribute to glucose excursions, leading to improved overall control and care.”